Curve Biosciences
Mountain View, US · Founded 2021 · Delaware corporation · 1 known investors
Platform using blood-based biomarkers and AI to detect and monitor chronic diseases like cirrhosis through organ-specific signals
Founders & leadership
CO
CHUBA OYOLUNamed on SEC filing
NH
NATHAN HUNKAPILLERNamed on SEC filing
SX
SHAN XIANG WANGNamed on SEC filing
RP
RITISH PATNAIKNamed on SEC filing
Board
TK
Investors · 1
Reported raises · per SEC filings
Form D private placements$17.7M disclosed across 1 round · 2024
▶$17.7MraisedMay 2024 · 64 investors · OtherRule 506(b)
▶$17.7MraisedMay 2024 · 64 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- CHUBA OYOLUExecutive Officer
- NATHAN HUNKAPILLERExecutive Officer
- SHAN XIANG WANGExecutive Officer, Director
- THEMASAP KHANDirector
- RITISH PATNAIKExecutive Officer, Director
- Offering amount
- $20M
- Amount sold
- $17.7M
- Minimum investment
- $1
- First sale
- May 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Curve Biosciences do?
- Platform using blood-based biomarkers and AI to detect and monitor chronic diseases like cirrhosis through organ-specific signals
- Who are Curve Biosciences's investors?
- Curve Biosciences's investors include Luma Group.
- How much funding has Curve Biosciences raised?
- Curve Biosciences has disclosed $17.7M raised across 1 round.
- Where is Curve Biosciences headquartered?
- Curve Biosciences is headquartered in Mountain View, US.